U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
189901189901Ipilimumab and Sargramostim in Treating Patients With Metastatic Prostate CancerActive, not recruitingNo Results AvailableRecurrent Prostate Carcinoma|Stage IV Prostate CancerBiological: Ipilimumab|Other: Laboratory Biomarker Analysis|Other: Pharmacological Study|Biological: Sargramostimhttps://ClinicalTrials.gov/show/NCT00064129
189902189902Combination Chemotherapy With or Without Rituximab in Treating Patients With Non-Hodgkin's LymphomaCompletedNo Results AvailableLymphomaBiological: rituximab|Drug: CHOP regimenhttps://ClinicalTrials.gov/show/NCT00064116
189903189903Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or PharynxCompletedNo Results AvailableLip and Oral Cavity Cancer|Oropharyngeal Cancer|Stage 0 Lip and Oral Cavity Cancer|Stage 0 Oropharyngeal Cancer|Tongue CancerBiological: Ad5CMV-p53 gene|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00064103
1899041899043-AP and Cytarabine in Treating Patients With Hematologic CancerCompletedNo Results AvailableLeukemia|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative NeoplasmsDrug: cytarabine|Drug: triapinehttps://ClinicalTrials.gov/show/NCT00064090
189905189905Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the CervixCompletedNo Results AvailableCervical Adenocarcinoma|Cervical Adenosquamous Carcinoma|Cervical Squamous Cell Carcinoma|Recurrent Cervical Carcinoma|Stage IVB Cervical CancerDrug: Cisplatin|Drug: Gemcitabine Hydrochloride|Drug: Paclitaxel|Other: Quality-of-Life Assessment|Drug: Topotecan Hydrochloride|Drug: Vinorelbine Tartratehttps://ClinicalTrials.gov/show/NCT00064077
1899061899063-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung CancerCompletedNo Results AvailableLung CancerDrug: gemcitabine hydrochloride|Drug: triapinehttps://ClinicalTrials.gov/show/NCT00064064
1899071899073-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic CancerCompletedNo Results AvailablePancreatic CancerDrug: gemcitabine hydrochloride|Drug: triapinehttps://ClinicalTrials.gov/show/NCT00064051
189908189908S0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage II, or Stage III Multiple MyelomaCompletedHas ResultsMultiple Myeloma|Plasma Cell NeoplasmDrug: dexamethasone|Drug: lenalidomide|Other: placebohttps://ClinicalTrials.gov/show/NCT00064038
189909189909Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine CorpusCompletedHas ResultsEndometrial CancerDrug: medroxyprogesterone|Genetic: microarray analysis|Procedure: conventional surgery|Procedure: neoadjuvant therapyhttps://ClinicalTrials.gov/show/NCT00064025
189910189910Bortezomib With or Without Docetaxel in Treating Patients With Relapsed or Refractory Advanced Non-Small Cell Lung CancerCompletedNo Results AvailableLung CancerDrug: bortezomib|Drug: docetaxelhttps://ClinicalTrials.gov/show/NCT00064012
189911189911Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial CancerActive, not recruitingNo Results AvailableEndometrial CancerBiological: filgrastim|Drug: carboplatin|Drug: cisplatin|Drug: doxorubicin hydrochloride|Drug: paclitaxelhttps://ClinicalTrials.gov/show/NCT00063999
189912189912Esophagectomy in Treating Patients With High-Grade Dysplasia of the Esophagus or Stage I, Stage II, or Stage III Esophageal CancerCompletedHas ResultsEsophageal CancerProcedure: Minimally invasive esophagectomy (MIE)https://ClinicalTrials.gov/show/NCT00063986
189913189913Cilengitide in Treating Children With Refractory Primary Brain TumorsCompletedNo Results AvailableChildhood Central Nervous System Germ Cell Tumor|Childhood Choroid Plexus Tumor|Childhood Craniopharyngioma|Childhood Ependymoblastoma|Childhood Grade I Meningioma|Childhood Grade II Meningioma|Childhood Grade III Meningioma|Childhood High-grade CerebellaDrug: cilengitide|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00063973
189914189914Hepatic Arterial Infusion With Floxuridine and Systemic Irinotecan After Surgery in Treating Patients With Hepatic (Liver) Metastases From Colorectal CancerCompletedNo Results AvailableColorectal Cancer|Metastatic CancerDrug: floxuridine|Drug: irinotecan hydrochloridehttps://ClinicalTrials.gov/show/NCT00063960
189915189915Erlotinib, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic CancerCompletedNo Results AvailableAdenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage II Pancreatic Cancer|Stage III Pancreatic CancerDrug: erlotinib hydrochloride|Drug: gemcitabine hydrochloride|Radiation: radiation therapy|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00063947
189916189916Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast CancerTerminatedHas ResultsMale Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast CancerBiological: oblimersen sodium|Drug: doxorubicin hydrochloride|Drug: docetaxel|Biological: filgrastim|Biological: pegfilgrastim|Procedure: therapeutic conventional surgery|Other: pharmacological study|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00063934
189917189917Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and NeckCompletedNo Results AvailableRecurrent Non-small Cell Lung Cancer|Recurrent Ovarian Epithelial Cancer|Recurrent Squamous Cell Carcinoma of the Hypopharynx|Recurrent Squamous Cell Carcinoma of the Larynx|Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity|Recurrent Squamous CDrug: erlotinib hydrochloride|Other: pharmacological study|Other: pharmacogenomic studies|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00063895
189918189918Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate CancerActive, not recruitingNo Results AvailableProstate CancerRadiation: iodine I 125|Radiation: palladium Pd 103|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00063882
189919189919Study Evaluating the Safety and Efficacy of Etanercept in Patients With Idiopathic Pulmonary FibrosisCompletedNo Results AvailablePulmonary FibrosisDrug: Etanercepthttps://ClinicalTrials.gov/show/NCT00063869
189920189920Dressing Preparations for SmallpoxCompletedNo Results AvailableSmallpoxBiological: Wetvax (APSV)https://ClinicalTrials.gov/show/NCT00063856
189921189921Anthrax-rPA: Safety, Tolerability, ImmunogenicityCompletedNo Results AvailableAnthraxBiological: Recombinant Protective Antigen, Anthrax Vaccine Adsorbedhttps://ClinicalTrials.gov/show/NCT00063843
189922189922ISIS 2302-CS27, A 6-Week, Placebo-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis.CompletedNo Results AvailableUlcerative ColitisDrug: Alicaforsenhttps://ClinicalTrials.gov/show/NCT00063830
189923189923Reducing the Risk of Transplant Rejection: Simultaneous Kidney and Bone Marrow TransplantCompletedNo Results AvailableKidney Failure|Bone Marrow Transplantation|Kidney Transplantation|Kidney Failure, ChronicDrug: MEDI-507|Procedure: Combined kidney and bone marrow transplant|Drug: Cyclosporine A|Drug: Rituximab|Drug: Corticosteroidshttps://ClinicalTrials.gov/show/NCT00063817
189924189924Safety of AMD070 When Administered Alone or Boosted With Low-Dose Ritonavir in HIV Uninfected MenCompletedNo Results AvailableHIV InfectionsDrug: Ritonavir|Drug: AMD070https://ClinicalTrials.gov/show/NCT00063804
189925189925A Study to Assess Two Different Strategies of Combining Dexamethasone and VELCADENo longer availableNo Results AvailableMultiple MyelomaDrug: Bortezomibhttps://ClinicalTrials.gov/show/NCT00063791
189926189926Safety of an HIV Vaccine (AVX101) in HIV Uninfected Volunteers in the United States and South AfricaCompletedNo Results AvailableHIV InfectionsBiological: AVX101|Other: placebohttps://ClinicalTrials.gov/show/NCT00063778
189927189927Evaluation of Safety of Ciliary Neurotrophic Factor Implants in the EyeCompletedNo Results AvailableRetinitis PigmentosaDrug: Ciliary Neurotrophic Factor Implant NT-501https://ClinicalTrials.gov/show/NCT00063765
189928189928Safety Study of PI-0824 to Treat Pemphigus VulgarisCompletedNo Results AvailablePemphigus VulgarisDrug: PI-0824https://ClinicalTrials.gov/show/NCT00063752
189929189929A Study of PS-341 Given to Patients With Multiple Myeloma Who Experienced Progressive Disease After Receiving Dexamethasone in M34101-039CompletedNo Results AvailableMultiple MyelomaDrug: bortezomibhttps://ClinicalTrials.gov/show/NCT00063726
189930189930VELCADE in Subjects With Relapsed or Refractory Mantle Cell LymphomaCompletedNo Results AvailableMantle Cell LymphomaDrug: VELCADE TM (bortezomib) for Injectionhttps://ClinicalTrials.gov/show/NCT00063713

* Görseller ve İçerik tekif hakkına sahip olabilir